G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/92 (2006.01)
Patent
CA 2662987
Novel methods for assessing the level of triglycerides in the liver of a subject are described, comprising determining the amount of a lipid metabolite in a sample from a body fluid of the subject. The methods may be used, for example, in diagnosing and monitoring liver disorders such as steatosis, NAFLD and NASH.
La présente invention concerne de nouveaux procédés qui permettent d'évaluer le niveau de triglycérides dans le foie d'un sujet et consistent à déterminer la quantité d'un métabolite lipidique dans un échantillon de fluide corporel prélevé sur le sujet. Les procédés peuvent être utilisés, par exemple, pour le diagnostic et le suivi de troubles hépatiques tels que la stéatose, la NAFLD et la NASH.
Baillie Rebecca A.
Watkins Steven M.
Wiest Michelle M.
Fetherstonhaugh & Co.
Tethys Bioscience Inc.
LandOfFree
Markers of non-alcoholic fatty liver disease (nafld) and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Markers of non-alcoholic fatty liver disease (nafld) and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Markers of non-alcoholic fatty liver disease (nafld) and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1769564